FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the use of the following compounds or their pharmaceutically acceptable salts for the preparation of a pharmaceutical composition for the treatment and / or prevention of a disease or disorder associated with hepatitis virus, where the disease or disorder associated with hepatitis virus is selected from hepatitis A, hepatitis B, hepatitis C and cirrhosis of the liver. The invention also relates to the use of a pharmaceutical composition for the treatment and / or prevention of a disease or disorder associated with the hepatitis virus, where the disease or disorder associated with the hepatitis virus is selected from hepatitis A, hepatitis B, hepatitis C and liver cirrhosis, containing a compound of the selected from those listed below, and a drug known for the treatment of HBV, selected from tenofovir disoproxil fumarate, IFNα-2a, Birinapant and anti-PD1 antibodies.
EFFECT: invention is used for the treatment and / or prevention of a disease or disorder associated with hepatitis virus.
6 cl, 8 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATMENT OF HEPATITIS B INFECTION | 2018 |
|
RU2780021C2 |
| CAPSID PROTEIN ASSEMBLY INHIBITOR CONTAINING N-HETEROCYCLIC FIVE-MEMBERED RING, ITS PHARMACEUTICAL COMPOSITION AND USE | 2019 |
|
RU2802259C2 |
| PEGYLATED RECOMBINANT CONSENSUS INTERFERON VERSION CONJUGATE AND PREPARATION METHOD AND USE THEREOF | 2011 |
|
RU2575796C9 |
| METHOD OF TREATMENT OF ACUTE VIRAL HEPATITIS B | 2001 |
|
RU2207135C2 |
| METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
| METHOD OF TREATMENT OF CHILDREN WITH VIRAL HEPATITIS B | 1998 |
|
RU2154478C2 |
| METHOD FOR PREDICTION OF CHRONICITY OF VIRAL HEPATITIS B IN CHILDREN WITH FOOD ALLERGY | 2013 |
|
RU2531938C1 |
| IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
| METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
| MEANS AND METHODS OF PREDICTING RESPONSE TO TREATMENT OF HEPATITIS B | 2013 |
|
RU2640256C2 |
